BIO-Europe Spring 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

BIO-Europe Spring 2013


BIO-Europe Spring® 2013 — 7th International Partnering Conference
Where the global biotech industry comes to partner

Location:
Barcelona, Spain

Date:
March 11–13, 2013

Venue:
CCIB Convention Centre Barcelona

Venue address:
CCIB Convention Centre
Rambla Prim 1–17
08019 Barcelona
Spain

Venue website:
www.ccib.es

Event Website:
www.ebdgroup.com/bes

The seventh annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2013 edition, BIO-Europe Spring comes to Barcelona, Spain on March 11–13, 2013.

The conference annually attracts the international “who’s who” from biotech, pharma and finance for three days of high caliber networking. BIO-Europe Spring’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. Attend BIO-Europe Spring and take advantage of the opportunity for more partnering meetings in the three days of the conference than in the rest of the year.

Based on attendance at previous events, BIO-Europe Spring 2013 will bring together more than 2,200 executives from biotechnology, pharmaceutical and finance companies from around the world, who will engage in some 12,000 partnering meetings.

Partnering at BIO-Europe Spring is powered by partneringONE®, the leading conference solution for helping life science delegates meet efficiently and effectively. partneringONE has the unique ability to manage the complex interactions among thousands of executives from many different companies.

This sophisticated web-based partnering system enables delegates to screen potential partners, pre-arrange meetings and manage the entire conference partnering process.

Delegates can log in and connect with the conference community, anytime, anywhere.

Producer:
EBD Group AG

Supported by:
Biotechnology Industry Organization (BIO)

Contacts:
In the USA
Christina Hundschell
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 030 0520
chundschell@ebdgroup.com

In Europe
Manuela Hildebrand
Isartorplatz 4
80331 Munich
Germany
T: +49 89 23 88 756 0
F: +49 89 23 88 756 55
mhildebrand@ebdgroup.com

Intended for:
Executives from:

  • Established and emerging biotech and medtech companies
  • Pharmaceutical companies
  • Institutional financial firms
  • Private investors including venture capital and private equity firms
  • Other industry related service companies

Speakers:
Please see website

Cost:
Please see website: http://www.ebdgroup.com/bes/registration

Program:
Please see website: http://www.ebdgroup.com/bes/program/index.php

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here